Two Biotechs I’m Buying Amid an Overbought Market
As retailers get hit and AI-plays bubble over, I’ve got my sights on these two promising biopharma stocks.
As retailers get hit and AI-plays bubble over, I’ve got my sights on these two promising biopharma stocks.
I’m looking forward to a break from the heat, but not to these economic worries that could add to already poor seasonality.
Trump and Canada talk tariff deal, Venezuela oil production and other headlines moving the market this morning.
As peace eludes and perils grow in Middle East, why hasn’t oil run wild … yet? Also, the ‘BUZZ’ on chips and trouble n China.
We added to one holding this week, and locked in outsized gains for two others.
Weak retail sales gapped the market up but it rolled over anyway.
Here’s my game plan and take on the market action, incoming economic data, and volatile geopolitical scene.
We added three new holdings this week, diversifying our lineup, and locked in massive gains across three others.
We raised a few price targets, added to three holdings, and locked in big gains in another.